Tolerance study of tetrodotoxin injection in opioid-dependent patients in the convalescent stage

FAN Hua-ying,LIANG Jun-cheng,ZHOU Fen,SUN Li,LI Xiao-xiao,XU Guo-zhu,DENG Yan-ping

DOI: https://doi.org/10.3969/j.issn.1008-5734.2012.03.002

2012-01-01

Abstract:Objective To observe the tolerance of tetrodotoxin injection in opioid-dependent patients in the convalescent stage.Methods An open,non-controlled trial was conducted.The opioid-dependent patients aged 18 to 45 years,male or female,during the convalescent stage were enrolled as subjects.Two different dosage regimens were used in the trial: a single-dose regimen(5 μg or 10 μg or 15 μg once daily intramuscularly) and multi-dose regimen(10 μg or 15 μg thrice daily intramuscularly for 7 days).During the trial phase,the changes in vital signs and adverse reactions were observed and recorded.Laboratory test and electrocardiogram(ECG) were performed before and after administration and all the results were statistically analyzed.Results A total of 30 subjects were enrolled in the study.Eighteen subjects receiving the single-dose regimen were randomly divided into the 5 μg,10 μg and 15 μg groups and 12 subjects receiving the multi-dose regimen were divided into the 10 μg and 15 μg groups.Each group comprised 6 subjects.During the trial phase,there were no marked changes in vital signs in all subjects.The levels of creatine kinase in the 5 μg and 10 μg groups receiving single-dose regimen and the 15 μg group receiving multi-dose regimen after injection of tetrodotoxin were significantly higher than those before drug administration(all P<0.05).The levels of alanine aminotransferase(ALT) and aspartate aminotransferase(AST) in one subject in the 5 μg group receiving single-dose regimen after injection of tetrodotoxin were higher than those before drug administration,and did not return to baseline 3 days after the trial completion.After tetrodotoxin injection administration,the levels of creatine kinase of 4 subjects in the 15 μg group receiving multi-dose regimen increased obviously and three of them decreased to normal level 3 days after the trial completion.An ECG revealed ST or T wave changes in 4 subjects receiving the single-dose regimen 24 hours after injection of tetrodotoxin and one subject receiving the multi-dose regimen 7 days after drug administration,and then ST or T wave changes normalised 3 days after the trial completion.Adverse reactions associated with tetrodotoxin injection occurred in 7 subjects,including xerostomia(6 subjects),fatigue(2 subjects),tongue numb(1 subject),limb pain(1 subject),the incidence of adverse reactions was 23.3%.The symptoms of adverse reactions spontaneously subsided or disappeared without withdrawal or dosage reduction.Conclusion Tetrodotoxin injection could be well tolerated in a dose of 5-15 μg 3 times a day by intramuscular injection in opioid-dependent patients in the convalescent stage.